Advances in staging and treatment of hepatitis B cirrhosis
10.3969/j.issn.1001-5256.2016.06.003
- VernacularTitle:乙型肝炎肝硬化的分期及治疗进展
- Author:
Yameng SUN
1
;
Hong YOU
Author Information
1. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China
- Publication Type:Research Article
- Keywords:
hepatitis B, chronic;
liver cirrhosis;
therapy;
prognosis;
editorial
- From:
Journal of Clinical Hepatology
2016;32(6):1036-1039
- CountryChina
- Language:Chinese
-
Abstract:
Liver cirrhosis is an important stage of the progression of chronic hepatitis B, and it is of great significance to clarify the severity of liver cirrhosis in evaluating prognosis. At present, the clinical staging based on the complications of liver cirrhosis is widely used, but pathological staging still needs to be refined. In the aspect of treatment, liver disease associations updated the guidelines for the diagnosis and treatment of chronic hepatitis B in 2015, and the antiviral therapy for hepatitis B cirrhosis has become more active. As for the prognosis, effective antiviral treatment realizes the reversion of early cirrhosis and reduces the incidence of liver-related complications, but the mechanism of reversion awaits further investigation.
